POET Investors Shrug Off Marvell Debacle As Stock Notches 50% Weekly Jump: Retail Confidence Improves

In late April, POET indicated that it had purchase orders linked to Marvell, which ultimately led to the loss of those contracts due to a breach of confidentiality.
Poet Technologies logo displayed on a smartphone screen. The company's stock rose over 23% on Tuesday (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)
Poet Technologies logo displayed on a smartphone screen. The company's stock rose over 23% on Tuesday (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)
Profile Image
Yuvraj Malik·Stocktwits
Published May 11, 2026   |   1:11 AM EDT
Share
·
Add us onAdd us on Google
  • POET shares gained 50% last week amid surging interest in photonic networking technology, seen as a key beneficiary of the rapid data center buildout.
  • Retail traders are upbeat, speculating that the company might formally announce new orders at its upcoming earnings report.
  • Stocktwits sentiment for POET was ‘neutral’ early Monday.

POET Technologies shares gained 50% last week, regaining the ground lost in the previous week after the company’s order commentary led to the cancellation of business with Marvell Technology and a sharp slide in stock.

The rally signals that investor interest in the photonic components space — particularly in POET — remains strong. Record levels of spending on new AI data centers, coupled with robust recent results from cloud companies, continue to bolster the outlook for data center-adjacent sectors, including chips, networking, and other infrastructure components.

Late last month, POET CFO Thomas Mika told Stocktwits in an interview that the company had received orders linked to Marvell, and that a few more from other customers were in the pipeline. Days later, the company said that those orders were canceled due to “contravention of its confidentiality obligations.” POET stock slide 47% on April 27, the day after the company’s disclosure.

Still, the POET stock regained steam as the new month kicked off.

Recent Catalysts For POET

Contributing factors in the last week included the launch of Defiance ETFs' POEL, a daily 2x-long single-stock leveraged ETF tracking POET, which amplified trading flows, visibility, and speculative interest. The fund aims to deliver 200% of the daily percentage change in POET's share price.

Positive governance moves around the Passive Foreign Investment Company (PFIC) status clarification and plans to redomicile in the U.S., announced in mid-April, appear to be providing tailwinds. Still, risks persist: the company has minimal revenue, ongoing losses, and extreme stock volatility driven more by flows and narrative rather than fundamentals. 

Meanwhile, several proposed class-action lawsuit notices — along with at least one lawsuit already filed — circulated on May 8, did little to derail the stock’s upward momentum.

Retail’s View On POET

On Stocktwits, the retail sentiment for POET inched higher on the weekend and was ‘neutral’ as of early Monday, with traders actively setting up trades ahead of POET’s first-quarter report expected in the coming weeks.

Screenshot 2026-05-11 at 10.23.31 AM.png
POET sentiment and message volume as of May 11 | Source: Stocktwits

“$POET this thing on fire - I see new all-time highs within 2 weeks and when they announce first order for next hyperscaler this thing gonna gap up into the $20S - mark it!” said a trader.

Another wrote: “$POET The entire market is bullish as it understands we need everything to do with AI. From memory sticks to photonics, it is all going up. Especially when we realize that giants like AWS go down if we don't have these. Supply and demand. Great momentum.”

POET has yet to announce the data for its earnings report. As of Friday, POET shares had gained 73% year-to-date.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Read Next: Akamai Stock Posts Best Week Since 2013 On Buzz Of $1.8B Anthropic Cloud Deal

 

Follow on Google News
Read about our editorial guidelines and ethics policy